Questionnaire for State Department of Health and Family Welfare

Size: px

Start display at page:

Download "Questionnaire for State Department of Health and Family Welfare"

Meryl Bradford
5 years ago
Views:

1 Questionnaire for State Department of Health and Family Welfare Name(s) of Research Investigator(s) Name of Hospital (OPTIONAL) Name(s) and Title(s) of Respondent(s) (OPTIONAL) Date, Time and Venue of Meeting 1. Which of the following functions fall under the mandate of your department? a) To develop state level policies for improving the healthcare related service in the state b) To improve the status of healthcare service in the state c) Capacity building of state level regulators for better implementation of polices and regulation d) All of the above e) Other (please specify..) 2. Are you aware of following rules/regulation/guidelines? i) Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) by Department of Pharmaceutical ii) National Voluntary Guidelines (NVGs) on Social, Environmental and Economic Responsibilities of Business by Ministry of Corporate Affaires iii) Professional Conduct, Etiquette and Ethics Regulations, 2002 by Indian Medical Council

2 3. What are your opinion about implementation of NVGs and other above mentioned guidelines/regulation (mention three main Opportunities & three main Challenges)? i) Opportunities (for instance, growing realisation of the importance of sustainability and responsibility of business) ii) Challenges (for instance, lack of commitment from the part of pharma firms, technological backwardness of small/medium firms etc.) 4. How effective these regulations have been for ensuring good corporate conduct from the part of pharmaceutical industry and healthcare sector. a. Highly effective.. b. Moderately effective. 5. Are you satisfied with its present form or would you like some amendment to be made, amendments are required (Please specify), these are fine 6. Is there a state level report regarding the overall status of healthcare system? If yes kindly provide a copy of it. 7. Kindly provide details regarding your interaction with the following entities. Entity Frequency Nature Agenda Improvement required Ministry of Health and Family Welfare Central Drug Standard Control Organisation FDCA Pharmaceutical Firms/Association Private Hospitals Association State Pollution Control Board Outcome

3 State /Local Health Administration State/Local Industry Collectives 8. Does your department acknowledge that there are certain ethical concern relating to the Incentive Structure associated with the interplays among different actors (drug manufacturer, stockiest, wholesaler, chemist, medical representatives, doctors) involved with marketing and distribution chain of drugs. 9. Kindly provide your views regarding the main problems related to marketing and distribution of drugs in pharmaceutical industry. 10. Can you elucidate the support that has been provided to FDCA by the Department of Health and Family Welfare? 11. What are the main challenges that you reckon the FDCA has to face today (rank them as well)? 12. How can these challenges be overcome? 13. Have there been (situation) reports prepared for the Pharma sector in the State? 14. Who according to you should be directly dealing with the issues related to Marketing and distribution of pharmaceutical firms? a. Pharmaceutical firms (individually) b. Association of Pharmaceutical firms c. Govt. agencies d. Other player related to the healthcare sector

4 Section C: - Environment 15. Kindly share your views regarding the environmental impact of pharmaceutical firms in the state. 16. What steps has been taken by your department to bring environmental concerns on the list of priority issues of pharmaceutical industry? 17. Are you aware of the Good Manufacturing Practices (GMP) norms set under the Schedule M of the Drugs & Cosmetics Act, 1940? 18. If yes, what specific mechanism has been adopted by your department to ensure adherence of GMP norms by the pharmaceutical companies. 19. What according to you would be three ways in which you think a department like yours can help to minimize the environmental impacts caused by pharmaceutical industry? What role should your department and Ministry of Health and Family Welfare (central level body) play in each of them? S.No. Improvements Role of Department of Health and Family Welfare Role of Ministry of Health and Family Welfare Are you conversant with the Bio Medical Waste (Management and Handling) rules 1998?

5 21. If yes what specific mechanism has been adopted by your department for ensuring complete adherence of the rule? 22. Does your department organize any meeting with State Pollution control Board and BMW entities in this regard? 23. In the final analysis, do you believe these issues are better solved in the long run on the basis of: a) Consistent and better informed government regulations b) Strict enforcement of regulations c) Self-regulation d) Any Other Section D: - Standard Treatment Protocol 24. What according to you has been the main reason for government mulling over the idea of standard treatment guidelines for both public as well as private sector hospitals? 25. Have your department ever organised any meeting with the hospital association and regulators for suggestions before finalizing such guidelines for private hospitals? What are your views regarding making the standard treatment protocol mandatory for private healthcare sector. 27. Have there been any initiatives taken by your department in accordance with the ministry of health and Family Welfare for encouraging private healthcare units to adopt self-regulation regarding standard treatment protocols?

6 28. What should be the role of the following to deal with the issue of violation of standard treatment protocols by the Private Healthcare sector: a. State Medical Council. b. State/Local Health Administration c. Private Healthcare Sector d. Hospital Association.. e. State level regulators f. Others.

The FDA Food Safety Modernization Act of 2009 Section-by-Section Summary

The FDA Food Safety Modernization Act of 2009 Section-by-Section Summary Title I Improving Capacity to Prevent Food Safety Problems Sec. 101. Inspection of Records Gives FDA expanded access to food facility